OncoCyte's total assets for Q4 2024 were $35.08M, a decrease of -50.04% from the previous quarter. OCX total liabilities were $47.35M for the fiscal quarter, a -21.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.